3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Warts
2
Neurofibromatosis 1
2
Breast Neoplasms
2
Stomatitis
1
Retinoblastoma
1
Retinal Neoplasms
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Neoplasms
1
Osteoma, Osteoid
1
Nevus of Ota
1
Neurofibromatoses
1
Neoplasms
1
Mucositis
1
Lymphedema
1
Keratosis, Actinic
1
Hemangioma, Capillary
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Atrophy
1
Interventions
Carboplatin
23
Etoposide
19
Vincristine
16
Melphalan
13
Filgrastim
13
Topotecan
10
Granulocyte Colony-Stimulating Factor
9
Cyclophosphamide
8
Thiotepa
7
Cryotherapy
7
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Doxorubicin
3
Busulfan
3
Brachytherapy
3
Temozolomide
2
Radiotherapy
2
Platinum Compounds
2
Magnetic Resonance Imaging
2
Ifosfamide
2
Eye Enucleation
2
Cisplatin
2
Blood Specimen Collection
2
trioctyl phosphine oxide
1
sargramostim
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
omburtamab I-131
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Retinoblastoma
×
Lasers
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled